Quick Answer
Pulmatrix, Inc. reported Diluted EPS of $1.41 per share (loss) for fiscal year 2025.
Pulmatrix, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.41 | +46.2% |
| 2024 | -$2.62 | +32.3% |
| 2023 | -$3.87 | +29.1% |
| 2022 | -$5.46 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.24 | +66.2% | +42.9% |
| June 30, 2025 | -$0.42 | +73.6% | -184.0% |
| March 31, 2025 | $0.50 | +117.4% | +170.4% |
| September 30, 2024 | -$0.71 | +31.1% | +55.3% |
| June 30, 2024 | -$1.59 | -52.9% | -791.3% |
| March 31, 2024 | $0.23 | +118.9% | +122.3% |
| September 30, 2023 | -$1.03 | +29.0% | +1.0% |
| June 30, 2023 | -$1.04 | +23.5% | +14.8% |
- Pulmatrix, Inc. showed an increase of +46.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Pulmatrix, Inc.’s diluted eps has grown by 74.2% (from $5.46 per share (loss) to $1.41 per share (loss)).
- The most recent figure is from Pulmatrix, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: